SHALLCROSS STEVEN A 4
4 · Synthetic Biologics, Inc. · Filed Dec 27, 2021
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Award
Stock Options (right to buy)
2021-12-23+650,000→ 650,000 totalExercise: $0.33From: 2022-01-23Exp: 2028-12-23→ Common Stock (650,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 36 months.